About ALTURiX

Headquartered in Milton Keynes, ALTURiX can trace its origins back to 1998 when the rights for its three heritage products – Phosphate Sandoz^TM, Sando-K^®, and Slow Sodium^® – were acquired from Novartis.  These products have since been reliably supplied to the NHS, helping to improve patients’ health.  More recently, NACSYS^® CEYESTO^® Tablets, CEYESTO^® Oral Solution, and DEMOVO^® Oral Solution have been added to their rapidly growing portfolio. 

The company’s stated aim is to provide high-quality medicines at appropriate prices in markets where current prescriber and patient choices are limited, and in doing so repeatedly, develop a reputation for reliability and delivery of value.